No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects*
-
Arterial Occlusive Diseases / blood
-
Arterial Occlusive Diseases / chemically induced*
-
Arterial Occlusive Diseases / diagnosis
-
Arterial Occlusive Diseases / therapy
-
Biopsy
-
Female
-
Humans
-
Male
-
Middle Aged
-
Neoplasms / drug therapy*
-
Neoplasms / immunology
-
Neoplasms / pathology
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
-
Thrombosis / blood
-
Thrombosis / chemically induced*
-
Thrombosis / diagnosis
-
Thrombosis / therapy
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
pembrolizumab